2型糖尿病，这一全球性流行病，正悄然影响着近5亿成年人的健康，带来沉重的疾病负担。近年来，科学家们不断探索2型糖尿病与肿瘤之间的复杂 ...

糖尿病酮症酸中毒（DKA）期间低磷血症很常见，且在严重酸中毒时更为明显。磷的丢失增加是由于跨细胞转移、渗透性利尿以及酸中毒和高血糖导致的肾脏近端小管对磷的重吸收减少。在使用胰岛素和补液治疗后，磷会转移到细胞内，在治疗开始后的中位时间 16 ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

与此同时，维生素 D 缺乏在人群中也较为普遍，即使在阳光充足的马来西亚也不例外。越来越多的证据表明，OSA 与维生素 D 缺乏之间存在着双向关联。此外，钠 - 葡萄糖协同转运蛋白 2 抑制剂（Sodium glucose transporter-2 inhibitor，SGLT2i）作为一种新型口服降糖药，除了能降低血糖外，还具有心血管保护作用。但目前关于维生素 D 补充剂以及 SGLT2i 在 ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

Type 2 diabetes is a global health challenge affecting more than 400 million adults. While it is often seen as a lifelong ...

For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual sodium ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...

Depression risk for patients receiving GLP-1 RA was slightly higher than those receiving SGLT-2i and lower than those receiving DPP-4i.

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...